Summary DNA index and S-phase fraction (SPF) were Multivariate analysis using the Cox model suggested that, while SPF gave prognostic information independent of tumour size or nodal status, this independent significance was lost when histological grade was included in the analysis.
The number of axillary lymph nodes involved by tumour is the single most important prognostic factor for women with primary breast cancer (Fisher et al., 1968) . Both oestrogen and progesterone receptor levels also have predictive value, patients with receptor negative tumours having a shorter relapse-free survival and overall survival (Allegra et al., 1979; Mason, 1983) , this effect being most apparent after first relapse (Stewart et al., 1981) . However, these prognostic factors alone do not fully account for the varied clinical course seen in breast cancer patients. In recent years, the proliferative rate of tumours has been widely investigated in an attempt further to define prognostic subgroups. Flow cytometry enables the automated measurement of both the amount of cellular DNA and the percentage of cells in different phases of the cell cycle. It can be performed on paraffin embedded tissue, thus allowing a retrospective evaluation of the relationship between these variables and clinical outcome.
Many studies have shown correlations between cellular DNA content, as measured by flow cytometry, and other pretreatment factors (Moran et al., 1984; Kute et al., 1985; Thorud et al., 1986; Dressler et al., 1988; Feichter et al., 1988) . Fewer have examined the relationship between the results of flow-cytometric DNA analysis, in particular Sphase fraction, and clinical course. In those studies which have been reported the results are not clearcut. Patients whose tumours have a low proportion of cells in S phase do appear to have a better prognosis (Kallioniemi et al., 1986) . Recent reports also show a relapse-free survival and survival advantage for patients with diploid tumours (Cornelisse et al., 1987; Hedley et al., 1987; Kallioniemi et al., 1987) , although this finding is not universal (Klintenberg et al., 1986) , and may be confined to sugroups defined by other prognostic factors (Cornelisse et al., 1987) .
The aim of this study was to assess the relationship between the results of DNA flow cytometry and clinical outcome in patients followed up for a minimum of 8 years. Flow cytometry was performed on cell suspensions prepared from formalin fixed paraffin embedded tissue from the primary tumour as described previously (Masters et al., 1987) . Briefly, 50gm sections were cut, dewaxed, rehydrated through a series of alcohols into water and treated in a 5 mg ml-' solution of pepsin at 37°C for 30 min at pH 1.5.
After needling, filtration through 35 gm pore sized polyester gauze and incubation with I jig ml-' DAPI (4'6-diamidino-2-phenylindol-dihydrochloride, Boehringer) the samples were analysed using a Becton Dickinson FACS Analyser powered by a mercury arc lamp. At (Camplejohn et al., 1989) .
Histological grade
The histological grade of infiltating ductal tumours was assessed by the method of Bloom and Richardson (1957) . All assessments of grade were made by a single observer (RRM). Tumours were classified as grade I (well differentiated), grade differentiated) using a system which takes into account mitotic activity, nuclear pleomorphism and tubule formation.
Steroid receptor assays
Oestrogen and progesterone receptor analysis was performed by the method of King et al. (1979) . For both receptors a level of at least 10 fmol mg-' cytosol protein was taken as positive.
Statistical analysis
Possible correlations between the results of DNA analysis and tumour size, histological grade, steroid receptor content and number of axillary lymph nodes involved were examined using x2-analysis. The Mann-Whitney test was used to measure differences between median S phase values. Univariate analysis by the log rank test was used to assess the influence of ploidy and SPF on relapse-free survival, overall survival and survival after relapse, and a multivariate analysis using the stepwise Cox regression model (Cox, 1972) was performed. Relapse-free survival was measured from the date of primary treatment to date of first relapse (locoregional or metastatic) (Hayward et al., 1977) There was no significant difference in relapse-free survival, overall survival or survival after relapse between diploid and aneuploid tumours (Figure 1 ). There was, however, a strong correlation between low SPF and longer relapse-free survival (Figure 2a ), overall survival ( Figure 2b ) and survival after relapse (Figure 2c ).
Multivariate analysis
The stepwise Cox regression model was used to assess the independent prognostic significance of the pretreatment variables measured. SPF, axillary nodal status, tumour size and histological grade were entered as factors in the analysis. SPF continued to give independent prognostic information for RFS, overall survival and survival after relapse following the inclusion of nodal status and tumour size (Table IV) . However with the inclusion of histological grade as a variable, the independent prognostic significance of SPF was lost, suggesting that the effect of SPF is mainly explained by its strong correlation with grade.
Discussion
The proportion of diploid tumours in our study (31.4%) is comparable with that reported by other centres (Moran et al., 1984; Kute et al., 1985; Thorud et al., 1986) . The median SPF (7.1) is also close to that reported by others (McDivitt et al., 1985; Kallioniemi et al., 1986; Dressler et al., 1988) . There are problems associated with the calculation of SPF for both diploid and aneuploid breast tumours. For diploid tumours, contamination by lymphoid and other non-malignant cells can lead to a falsely low result for SPF. For aneuploid tumours, the histograms of the aneuploid and diploid sub-populations overlap, making calculation of the SPF less accurate. The median SPF of diploid tumours in this study (3.2%), however, was significantly lower than that of aneuploid tumours (10.1%). This is in agreement with the results of thymidine labelling studies estimating SPF in both diploid and aneuploid tumours (McDivitt et al., 1985) , and suggests that we are measuring the SPF of two different populations of tumours, diploid and aneuploid.
High SPF and aneuploidy were both strongly associated ._O with histologically poorly differentiated tumours, as has been reported in many studies (Moran et al., 1984; Thorud et al., 1986; Feichter et al., 1988) . The absence of correlation between the results of flow-cytometric DNA analysis and either tumour size or axillary lymph node involvement has also been noted by others (Moran eta I., 1984; Kute et al., 1985; Feichter et al., 1988) , and suggests that DNA analysis and tumour stage provide different and independent information about tumour biology.
Most recent studies have reported a weak but consistent association between high SPF, aneuploidy and negative receptor status (Moran et al., 1984; Cornelisse et al., 1987; Feichter et al., 1988) , although this is not a universal finding (McDivitt et al., 1986; Klintenberg et at., 1986 (Kallioniemi et al., 1986; Hedley et al., 1987) . While longer relapse-free survival and overall survival were seen in our patients with diploid tumours, the improvement did not reach statistical significance.
In order to examine the relative importance of DNA analysis as a prognostic factor in breast cancer the independent prognostic significance of these results must be assessed.
The pretreatment variable most strongly associated with both ploidy and SPF in our patients was histological grade of the tumour, which is itself a good predictor of clinical outcome, patients with poorly differentiated tumours having a shorter relapse-free and overall survival (Bloom & Richardson, 1957) . Multivariate analysis using the Cox model suggested that SPF did provide prognostic information independent of primary tumour size and axillary nodal status. Tumour grade and SPF gave similar prognostic information on univariate analysis, with grade being a marginally better predictor of outcome. As tumour grade and SPF were very strongly correlated, however, the inclusion of tumour grade in the multivariate analysis abolished the independent significance of SPF. Thus, DNA analysis did not seem to give information additional to that already obtained by assessment of histological grade. Flow cytometric DNA analysis, however, has the advantage of being an objective process which is not as observer dependent. Inter-observer variation in grading breast cancer can be considerable, with one study showing agreement in only 23 of 158 tumours graded independently by six observers, five of whom had been simultaneously trained at the same institution (Delides et al., 1982) .
This study confirms recent reports in showing an improved relapse-free and overall survival for patients with low SPF in a group of patients with relatively long follow-up. The only other prognostic factor found to be significantly associated with the results of DNA analysis was histological grade. While DNA analysis did not give information independent of tumour grade, it is a less subjective measurement. We are at present analysing the results of DNA analysis in a larger group of patients to assess whether it gives independent prognostic information within subgroups.
